. 2017 Feb 4;8(11):17510–17517. doi: 10.18632/oncotarget.15102

Table 2. Univariate and partial correlations with circulating full-length betatrophin levels in patients with metabolic syndrome.

	Betatrophin r	P value	Betatrophin (age, sex and BMI adjusted) r	P value
Age	−0.039	0.797	-	-
BMI	−0.064	0.670	-	-
Waist circumference	0.003	0.981	0.049	0.750
Hip circumference	−0.127	0.396	−0.115	0.456
WHR	0.151	0.311	0.139	0.368
HbA1c	0.246	0.095	0.239	0.118
FPG^&	0.357	0.014	0.350	0.020
TG^&	0.204	0.168	0.177	0.251
TC	−0.089	0.553	−0.124	0.424
HDL-C	−0.19	0.200	−0.180	0.242
LDL-C	−0.200	0.178	−0.210	0.171
Creatinine	0.136	0.361	0.105	0.496
eGFR	−0.127	0.396	−0.171	0.268
UA	0.050	0.739	−0.002	0.988
ALT	−0.089	0.554	−0.117	0.450
AST	−0.114	0.447	−0.144	0.350
ALP	0.212	0.153	0.219	0.154
GGT^&	0.233	0.115	0.234	0.126
ALB	−0.207	0.162	−0.267	0.079
TBIL^&	0.053	0.607	0.089	0.397
DBIL	0.058	0.699	0.078	0.613
IBIL	0.163	0.275	0.167	0.280
HOMA1-IR	0.208	0.16	0.235	0.124
1/ HOMA1-IR	−0.141	0.343	−0.155	0.314
HOMA1-β (%)	−0.014	0.927	−0.006	0.969
HOMA2-%B	−0.095	0.523	−0.097	0.531
HOMA2-%S	−0.077	0.609	−0.086	0.578
HOMA2-IR	0.125	0.403	0.154	0.317
1/ HOMA2-IR	−0.078	0.605	−0.087	0.572
Glucose₁₂₀	0.38	0.008	0.372	0.013
Insulin₀^&	0.070	0.640	0.090	0.563
Insulin₁₂₀	−0.037	0.805	−0.051	0.741

^& indicates log-transformed variables.

Abbreviations: HOMA1-IR, homeostasis model assessment 1 to estimate insulin resistance; HOMA1-β, homeostasis model assessment 1 to estimate β-cell function; HOMA2-%B, homeostasis model assessment 2 to estimate β-cell function; HOMA2-IR, homeostasis model assessment 2 to estimate insulin resistance; HOMA2-%S, homeostasis model assessment 2 to estimate insulin sensitivity.